English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Plus annual

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Tools annual

Global: Zendy Free Plan

Global: Zendy Tools monthly

Global: Zendy Plus monthly

Background  Chronic kidney disease (CKD) patients have a high prevalence of coronary artery disease and a high risk of cardiovascular events. The present study assessed the value of the CHA 2 DS 2 -VASc score for predicting mortality among hospitalized acute coronary syndrome (ACS) patients with CKD.    Methods  This was a retrospective cohort study that included CKD patients who were hospitalized for ACS from January 2015 to May 2020. The CHA 2 DS 2 -VASc score for each eligible patient was determined. Patients were stratified into two groups according to CHA 2 DS 2 -VASc score: &amp;lt;6 (low) and ≥6 (high). The primary endpoint was all-cause mortality.    Results  A total of 313 eligible patients were included in the study, with a mean CHA 2 DS 2 -VASC score of 4.55 ± 1.68. A total of 220 and 93 patients were assigned to the low and high CHA 2 DS 2 -VASc score groups, respectively. The most common reason for hospitalization was unstable angina (39.3%), followed by non-ST-elevation myocardial infarction (35.8%) and ST-elevation myocardial infarction (24.9%). A total of 67.7% of the patients (212/313) received coronary reperfusion therapy during hospitalization. The median follow-up time was 23.0 months (interquartile range: 12–38 months). A total of 94 patients (30.0%) died during follow-up. The high score group had a higher mortality rate than the low score group (46.2 vs. 23.2%, respectively;  p  &amp;lt; 0.001). The cumulative incidence of all-cause death was higher in the high score group than in the low score group (Log-rank test,  p  &amp;lt; 0.001). Multivariate Cox regression analysis indicated that CHA 2 DS 2 -VASc scores were positively associated with all-cause mortality (hazard ratio: 2.02, 95% confidence interval: 1.26–3.27,  p  &amp;lt; 0.001).    Conclusion  The CHA 2 DS 2 -VASc score is an independent predictive factor for all-cause mortality in CKD patients who are hospitalized with ACS. This simple and practical scoring system may be useful for the early identification of patients with a high risk of death.

Predictive Value of the CHA2DS2-VASc Score for Mortality in Hospitalized Acute Coronary Syndrome Patients With Chronic Kidney Disease